Hand Hygiene Signs
OtherHand hygiene signs will not be changed (control) or change weekly/monthly on wards/units randomized to each of these study arms. Signs will be posted by the hand hygiene sanitizer outside each patient room.
NCT Number: NCT02223455
Hand hygiene is the single most effective practice in preventing the spread of hospital-acquired infections. Despite the strength of the evidence, hospital staff continue to sanitize their hands less than half of the time required by guidelines. Effective interventions are needed to improve hand hygiene compliance rates among hospital staff, but most are of poor quality and do not examine the specific effects of individual interventions. This study will build a "bundle" of three hand hygiene interventions using a research design that allows for the effectiveness of each intervention to be measured individually and combined.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Miami VA Healthcare System, Miami, FL, Miami, Florida, United States
The two specific aims and associated hypotheses of CREATE Project 2 include:
Hypothesis 1: Combinations of interventions will increase compliance rates more than single interventions.
Aim 1 will entail a 30-month cluster-randomized controlled trial that will sequentially test three individual hand-hygiene interventions - hand-hygiene point-of-use reminder signs to serve as an environmental cue to action, individual hand sanitizers, and health care worker hand cultures - to identify an optimal combination of interventions to increase hand-hygiene compliance. The trial will be conducted in 59 hospital units in 10 VA hospitals in order to test the efficacy of individual and then sequentially added interventions to determine their incremental impact on hand-hygiene compliance.
The focus for this clinical trial will be on Aim 1--Single Hand Hygiene Sign changes.
Hypothesis 2: Facilitators and barriers will pattern around contextual factors such as level of leadership support and organization of infection control programs.
Aim 2 will entail a qualitative process evaluation that includes site visits to purposefully selected sites, semi-structured interviews, and observations to examine barriers and facilitators to the interventions and develop contextual insight for implementing and scaling-up the intervention at additional sites as a national initiative.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
None
Hand hygiene signs will not be changed (control) or change weekly/monthly on wards/units randomized to each of these study arms. Signs will be posted by the hand hygiene sanitizer outside each patient room.
Time frame: phase 1 (7-12 months) thru phase 3 (19-21 months)
Hand hygiene compliance is the primary outcome measure. Compliance rates will be determined using the same methods of direct observation of HCWs developed by Dr. Perencevich for his VA Health Services Research & Development (HSR&D) funded study (IIR 09-099). Compliance will be collected monthly throughout the project for each of the 59 units.
VA Office of Research and Development
Fed
Building an Optimal Hand Hygiene Bundle: A Mixed Methods Approach
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03992209
Cross Infection, Disease Attributes
Aurora, Colorado, United States
View Trial DetailsNCT04053257
Cross Infection, Disease Attributes
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT06420934
Cross Infection, Disease Attributes
Bogotá, Bogota D.C., Colombia
View Trial DetailsNCT07654712
Acute Respiratory Tract Infections, Adherence Interventions
Istanbul, Turkey (Türkiye)
View Trial Details